Black Women Targeted with Eugenics Drug*
A deadly carcinogen offered as a ‘contraceptive’ has been on the U.S. drug market since the early 1990s, and population control organizations like Planned Parenthood continue to push it heavily on black women and other ethnic minorities as a form of contraception. But the injectable contraceptive drug Depo-Provera, manufactured by Pfizer, has an extensive track record of causing serious harm to women, including its tendency to trigger the development of cancer.
Most people are unaware of this and many of the other long-term side effects of Depo-Provera, because eugenics groups like Planned Parenthood erroneously claim the drug is “safe, effective and convenient.” But the non-profit Rebecca Project for Human Rights (RPHR) recently issued a groundbreaking report outlining the adverse effects of this insidious birth control shot, which currently bears a “black box warning” issued by the U.S. Food and Drug Administration (FDA) back in 2004.
This warning clearly states that women who receive Depo-Provera could develop significant and irreversible bone mineral density loss, for instance. The drug can also lead to blood clots in arms, legs, lungs and eyes and may also cause stroke, bleeding irregularities, weight gain, ectopic pregnancy and delayed return to fertility. In some cases, women who get jabbed with Depo-Provera become permanently sterile.
Perhaps most concerning is the fact that Depo-Provera has been shown to more than double a woman’s risk of developing breast cancer. A 2012 study out of the Fred Hutchinson Cancer Research Center in Seattle found that, compared to women who had never received a Depo-Provera shot, jabbed women were about 220 percent more likely to develop the disease, regardless of their family and medical histories.
Gates Foundation, USAID behind ongoing Depo-Provera eugenics conspiracy
But according to RPHR, none of these catastrophic risk factors has deterred groups like the Bill & Melinda Gates Foundation, the United States Agency for International Development (USAID), Columbia University and others from aggressively pushing this horrific jab on unsuspecting women both domestically and abroad. The group’s report draws attention to the fact that these organizations have committed medical violence against women, particularly in third-world countries, by administering the shot time and time again without informed consent.
“The story of Rebecca Project for Human Right’s struggle to unmask Depo Provera as a deadly contraceptive for women is important, because it demonstrates the deeply rooted cultural hegemony of population control and corporate profits put before humanity at any cost,” explains the report, entitled Depo-Provera: Deadly Reproductive Violence Against Women. It goes on to highlight numerous Depo-Provera experiments that have taken place against women in the U.S., Ghana and elsewhere.
Federal government continues to endorse Depo-Provera, despite deadly adverse effects
Food and Drug Administration (FDA) Black-Box warnings7 are the most stringent mandated warnings notifying patients on the significant risk of serious and life-threatening side effects or adverse effects that a drug may have. Therefore, all health professionals are required by FDA to inform patients of the likelihood of harm. Black Box warnings obligate all health providers including pharmacists dispensing a drug with Boxed warnings to counsel patients/consumers about serious side effects. However, as a regulated injectable contraceptive with a Black Box warning, Depo Provera is never dispensed by a pharmacist directly to a patient to self-inject in the US. According to the FDA labeling, Depo Provera should be administered by health professionals by injection after patients are counseled on the serious side effects. Therefore, the legal obligation to counsel women about serious side effects rests with birth control corporations, providers and agents directly promoting, distributing and administering Depo Provera injections to women. Consequently, by fraudulently minimizing or concealing harm to misinform women about Depo Provera’s Black Box warnings those corporations, providers and agents are violating federal law 21 Code of Federal Regulations paragraph 201.57(e).
Though many foreign governments have since outlawed medical experimentation on women with Depo-Provera, the U.S. continues to embrace the drug, as well as distribute it to overseas health contractors, according to Turtle Bay and Beyond. And the Gates Foundation and others continue to invest hundreds of millions of dollars into the distribution of Depo-Provera across the globe.
“The Rebecca Project for Human Rights urges the U.S. government to enforce mandatory FDA Black Box patient counseling requirements, and for health providers to obtain valid informed consent before Depo-Provera is administered in the United States, Africa, the Caribbean, Latin America, Southern Asia and the rest of USAID’s program areas,” concludes RPHR.
Depo-Provera (Depot Medroxyprogesterone Acetate – DMPA) is an injectable progesterone-contraceptive, which according to the Wall Street Journal’s Market Watch, Pfizer could potentially earn approximately $36 billion in sales.
The report notes:
UN data demonstrates that Depo Provera is seldom administered to White or affluent women and girls in the U.S. or Europe.
African American women have the highest usage percentage of Depo Provera in the United States, followed by Latinas.
South Africa and its neighboring countries continue to have the highest use of Depo Provera
In the U.S.
1967-1978: The largest test on humans of Depo-Provera begins and is conducted for eleven years through the Grady Clinic in Atlanta, Georgia on 14,000 low income women. These “trials” were conducted on women human subjects without being aware of the fact that they were part of an experiment; and, the researchers deliberately did not inform the women participants that Depo Provera had grave side effects. Many women developed cancer and/or died during the trials, but these cases were not reported to the FDA.
In 2011, according to the Centers for Disease Control and Prevention (CDC), Black women had 583,079 births, while white women had 2,150,926 births. The birth rates79 for Black women dropped dramatically by approximately 30% and for White women only 5%. Black people are only 13% of the US population.
The Outsourcing of Tuskegee: Nonconsensual Research in Africa46, researchers experimented with Depo Provera on approximately 9,000 impoverished women in the town of Navrongo and surrounding villages in the Kasena-Nankana districts of Ghana. The Navrongo Experiment47 was funded by: USAID, Population Council, Bill & Melinda Gates, Rockefeller and Andrew W. Mellon Foundations (1994-2006).
There is a reason why many African-American prefer birthing at home by a mid-wife, that reason is historical, but that is a history that demands to stand up and be counted.